+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07460765

Evaluating Safety and Imaging Use of Nivolumab-IRDye800CW in Adults Undergoing Surgery for Head and Neck Squamous Cell Carcinoma

Led by Vanderbilt-Ingram Cancer Center · Updated on 2026-10-16

40

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the safety and feasibility of using nivolumab-IRDye800CW nivo800 as a molecular imaging agent in adults diagnosed or presumed to have head and neck squamous cell carcinoma HNSCC who are scheduled for standard surgical removal of their tumor. This Phase 1 clinical trial aims to determine if administering nivo800 before surgery causes significant adverse effects and to assess the pathological response at varying dose levels, including tumor characteristics and immune cell presence. Participants will receive two intravenous infusions of nivo800 before surgery, one about 2 to 3 weeks prior and another 1 to 2 days before surgery. Different dose groups will receive varying amounts of the drug, with one group also receiving nivolumab alongside nivo800. After these infusions, participants will undergo their planned standard surgical tumor removal, during which tumor and lymph node samples will be collected for further pathological and imaging studies. During the study, participants will be closely monitored for safety within 15 days of drug administration, focusing on any adverse events related to the imaging agent. Tissue samples from surgery will be analyzed to understand the drugs effect on the tumor and surrounding tissues. The entire participation duration includes the preoperative infusions and surgery, with ongoing assessments to evaluate safety and imaging outcomes throughout the study period.

CONDITIONS

Brief Title

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

Research Team

M

Makenna Brown

N

Nicole Jones

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here